# Researching the Effectiveness of a Alivis, a Digital Health Application for Borderline Personality Disorder

> **NCT06601907** · NA · TERMINATED · sponsor: **Gaia AG** · enrollment: 286 (actual)

## Conditions studied

- Borderline Personality Disorder (BPD)

## Interventions

- **BEHAVIORAL:** alivis

## Key facts

- **NCT ID:** NCT06601907
- **Lead sponsor:** Gaia AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-09-23
- **Primary completion:** 2025-07-23
- **Final completion:** 2025-07-23
- **Target enrollment:** 286 (ACTUAL)
- **Why stopped:** An unplanned interim futility analysis was initiated due to differential dropout and participant feedback. The probability of achieving the pre-specified effect size was very low, and following DSMB review, the trial was terminated early.
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06601907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06601907, "Researching the Effectiveness of a Alivis, a Digital Health Application for Borderline Personality Disorder". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT06601907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*